Engler; Thomas Albert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engler; Thomas Albert.The latest application filed is for "pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors".

Company Profile

0.10.11

Engler; Thomas Albert - Indianapolis IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors Grant 9,624,218 - Chedid , et al. April 18, 2	2017-04-18
PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS App 20160251348 - CHEDID; Marcio ; et al.	2016-09-01
Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine Grant 8,648,063 - Chedid , et al. February 11, 2	2014-02-11
Potentiation Of Cancer Chemotherapy By 7-(2, 5- Dihydro- 4-imidazo [1, 2-a] Pyridine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 Tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] Benzodiazepine App 20130039996 - Aburub; Aktham ; et al.	2013-02-14
Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine Grant 8,318,713 - Chedid , et al. November 27, 2	2012-11-27
Purine Derivatives As Kinase Inhibitors App 20110294792 - Engler; Thomas Albert ; et al.	2011-12-01
Purine derivatives as kinase inhibitors Grant 8,058,425 - Engler , et al. November 15, 2	2011-11-15
Purine derivatives as kinase inhibitors Grant 8,022,065 - Engler , et al. September 20, 2	2011-09-20
Purine Derivatives As Kinase Inhibitors App 20110207721 - Engler; Thomas Albert ; et al.	2011-08-25
Potentiation Of Cancer Chemotherapy By 7-(2, 5- Dihydro- 4-imidazo [1, 2-a] Pyridine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 Tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] Benzodiazepine App 20100166884 - Aburub; Aktham ; et al.	2010-07-01
Purine Derivatives As Kinase Inhibitors App 20090105229 - Engler; Thomas Albert ; et al.	2009-04-23
TGF-.beta. inhibitors Grant 7,511,056 - Diefenbacher , et al. March 31, 2	2009-03-31
Purine derivatives as kinase inhibitors Grant 7,491,716 - Engler February 17, 2	2009-02-17
Tgf-Beta Inhibitors App 20080262004 - Diefenbacher; Clive Gideon ; et al.	2008-10-23
Compounds as pharmaceutical agents Grant 7,405,299 - Beight , et al. July 29, 2	2008-07-29
Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors Grant 7,405,305 - Albaugh , et al. July 29, 2	2008-07-29
Methods and compounds for treating proliferative diseases Grant 7,109,229 - Engler , et al. September 19, 2	2006-09-19
Novel compounds as pharmaceutical agents App 20060058295 - Beight; Douglas Wade ; et al.	2006-03-16
Kinase inhibitors App 20050288321 - Albaugh, Pamela Ann ; et al.	2005-12-29
Purine derivatives as kinase inhibitors App 20050090483 - Engler, Thomas Albert ; et al.	2005-04-28
Methods and compounds for treating proliferative diseases App 20040048915 - Engler, Thomas Albert ; et al.	2004-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.